WebMD Health Corp (NASDAQ:WBMD) issued its quarterly earnings results on Thursday. The company reported $0.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.67 by $0.06. The business had revenue of $207.47 million for the quarter, compared to the consensus estimate of $206.99 million. WebMD Health Corp had a net margin of 11.97% and a return on equity of 35.64%. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.60 EPS. WebMD Health Corp updated its FY17 guidance to $1.97-2.10 EPS.

Shares of WebMD Health Corp (NASDAQ:WBMD) opened at 51.51 on Friday. The company has a market capitalization of $1.93 billion, a PE ratio of 28.78 and a beta of 0.54. WebMD Health Corp has a one year low of $48.10 and a one year high of $67.55. The firm’s 50-day moving average price is $50.37 and its 200 day moving average price is $51.74.

Earnings History for WebMD Health Corp (NASDAQ:WBMD)

In related news, Chairman Martin J. Wygod sold 89,843 shares of the firm’s stock in a transaction on Monday, November 21st. The stock was sold at an average price of $53.94, for a total value of $4,846,131.42. Following the transaction, the chairman now owns 156,591 shares in the company, valued at $8,446,518.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Martin J. Wygod sold 14,321 shares of the firm’s stock in a transaction on Thursday, December 22nd. The stock was sold at an average price of $55.00, for a total value of $787,655.00. Following the completion of the transaction, the chairman now owns 134,637 shares in the company, valued at approximately $7,405,035. The disclosure for this sale can be found here. Insiders sold 388,416 shares of company stock worth $20,812,305 in the last 90 days. 8.10% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently modified their holdings of WBMD. Howard Hughes Medical Institute boosted its position in shares of WebMD Health Corp by 7.3% in the third quarter. Howard Hughes Medical Institute now owns 37,125 shares of the company’s stock worth $1,845,000 after buying an additional 2,517 shares during the last quarter. Pembroke Management LTD boosted its position in shares of WebMD Health Corp by 13.6% in the third quarter. Pembroke Management LTD now owns 421,800 shares of the company’s stock worth $20,963,000 after buying an additional 50,600 shares during the last quarter. Cookson Peirce & Co. Inc. boosted its position in shares of WebMD Health Corp by 149.5% in the second quarter. Cookson Peirce & Co. Inc. now owns 196,975 shares of the company’s stock worth $11,446,000 after buying an additional 118,030 shares during the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in shares of WebMD Health Corp by 0.5% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 1,137,414 shares of the company’s stock worth $56,529,000 after buying an additional 5,119 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its position in shares of WebMD Health Corp by 1,768.9% in the second quarter. Principal Financial Group Inc. now owns 147,753 shares of the company’s stock worth $8,586,000 after buying an additional 139,847 shares during the last quarter. Institutional investors own 86.66% of the company’s stock.

WBMD has been the topic of several research reports. Zacks Investment Research upgraded shares of WebMD Health Corp from a “hold” rating to a “buy” rating and set a $57.00 price target on the stock in a research report on Thursday, October 20th. Raymond James Financial, Inc. downgraded shares of WebMD Health Corp from a “strong-buy” rating to an “outperform” rating and set a $60.00 price target on the stock. in a research report on Monday, December 12th. Pacific Crest reiterated a “buy” rating and set a $72.00 price target on shares of WebMD Health Corp in a research report on Sunday, December 4th. Mizuho downgraded shares of WebMD Health Corp from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $63.00 to $52.00 in a research report on Wednesday, November 2nd. Finally, Citigroup Inc. upgraded shares of WebMD Health Corp from a “neutral” rating to a “buy” rating and set a $65.00 price target on the stock in a research report on Monday, January 30th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. WebMD Health Corp currently has an average rating of “Buy” and a consensus target price of $66.04.

This article was published by Daily Political and is the sole property of of Daily Political. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this article can be accessed at http://www.dailypolitical.com/2017/02/16/webmd-health-corp-wbmd-posts-quarterly-earnings-results-beats-estimates-by-0-06-eps.html.

About WebMD Health Corp

WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications. The WebMD Health Network includes: www.WebMD.com, its primary public portal for consumers and related mobile-optimized sites and mobile apps; www.Medscape.com, its primary public portal for physicians and other healthcare professionals and related mobile services; and other sites through which, the Company provides its branded health and wellness content, tools and services.

5 Day Chart for NASDAQ:WBMD

Receive News & Ratings for WebMD Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WebMD Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.